 |
인쇄하기
취소
|
En-Bio Technology's microsatellite analysis patented in 17 countries
En-Bio Technology said on October 26 that Cangen Biotechnologies Inc. has acquired a patent for its platform microsatellite analysis (MSA) technology from 17 countries from Australia. The Korean company acquired a larger share in Cangen last year.
Cangen has focused its initial efforts on developing a commercial MSA assay for use in the early detection of bladder cancer. The Cangen device is...
Cangen has focused its initial efforts on developing a commercial MSA assay for use in the early detection of bladder cancer. The Cangen device is...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.